Investment in Swiss Start-Ups Has Increased 36%!

Investment in Swiss Start-Ups Has Increased 36%!

Swiss Startup Investment Summary – H1 2025

Swiss startups raised CHF 1.47 billion in venture capital during H1 2025, marking the third-highest fundraising period on record. Despite strong capital deployment, deal volume decreased compared to H1 2024. Meanwhile, investor selectivity and larger average deal sizes also increased. This means that investors are choosing to focus on specific industries and companies, investing larger amounts of capital per transaction. As a result of this preference, some sectors received significantly more investment than others in the first half of 2025.

Confidence in Swiss Biotech Companies Increasing Significantly

When we analyzed the Swiss Venture Capital Report 2025, the biotech sector raised the highest investments by a considerable margin and dominated the funding landscape. This represents not only a difference between various sectors, but also a substantial increase compared to previous years. Biotech captured CHF 705 million, setting a new half-year record. The sector’s performance was driven by seven of the top 10 funding rounds, with five being early-stage transactions. This trend reflects strong institutional confidence in Swiss life sciences innovation and the sector’s operational maturity.

Although the biotech sector secured the largest investment amount in the first half of 2025, fintech and ICT sectors also experienced significant growth in their investment volumes. ICT and fintech sectors demonstrated robust recovery with substantial year-over-year capital increases. Notably, digital assets platform Sygnum Bank achieved unicorn status (>$1 billion valuation) through its latest funding round.

Is Basel Becoming the New Zurich for the Swiss Business World?

In the first half of 2025, Zurich raised the highest investment total with CHF 449.7 million. Capital inflows increased 80% year-over-year, though deal count fell from 60 to 49 transactions. Market share remained at a historically low 30.5%.

Basel achieved the second-highest investment level with record funding of CHF 420.5 million, nearly matching Zurich’s performance thanks to substantial biotech sector investments.

Zug doubled its capital to CHF 160 million, reinforcing its position as a key startup hub. With its favorable tax policies, Zug remains one of Switzerland’s leading startup centers.

Vaud failed to meet expectations, raising CHF 168 million—the lowest five-year figure for the canton.

Employment Market Implications: A Hiring Boom on the Horizon

This substantial funding surge translates directly into significant employment opportunities across Switzerland’s innovation ecosystem. With CHF 1.47 billion in fresh capital, Swiss startups are positioned to accelerate their hiring plans, creating thousands of new positions across multiple sectors.

Biotech Sector: High-Skilled Job Creation Engine

The biotech sector’s record CHF 705 million funding round will likely generate the most substantial employment growth. These investments typically fuel:

Research & Development positions: Laboratory technicians, research scientists, and clinical trial coordinators

Regulatory affairs specialists: Essential for navigating complex pharmaceutical approval processes

Manufacturing roles: As companies scale from research to production

Commercial positions: Sales, marketing, and business development roles for market expansion

Given that five of the seven major biotech investments were early-stage rounds, companies are building foundational teams, creating opportunities for professionals to join high-growth ventures at ground level.

Tech Sector Expansion: Digital Transformation Accelerates

The recovery in fintech and ICT sectors, exemplified by Sygnum Bank’s unicorn achievement, signals strong demand for:

Software engineers and developers: Full-stack, blockchain, and cybersecurity specialists

Data scientists and analysts: For AI/ML implementation and financial modeling

Product managers: To drive digital product development

Compliance and risk management: Particularly in fintech regulatory environments

These highest investments raised by the four main cantons—Zurich, Basel, Vaud, and Zug—represent the most promising job opportunities for the near future. Therefore, job seekers looking for employment in Switzerland should focus their attention on these regions.

Market Outlook: Quality Over Quantity

The funding environment reflects a “flight to quality” phenomenon, with investors concentrating capital in fewer, higher-value opportunities. This trend suggests:

Higher-paying positions: Well-funded companies can offer competitive salaries and equity packages

Long-term career stability: Substantial funding rounds provide companies with extended runways

Skills premium: Increased competition for specialized talent, particularly in biotech and fintech

For job seekers, this funding boom represents an opportune moment to join Switzerland’s most promising startups, with the potential for significant career advancement as these companies scale and mature.

CALL US